FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileKiaro Holdings Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
KIARF
Kiaro Holdings Corp. Stock AnalysisComprehensive stock analysis for Kiaro Holdings Corp. (KIARF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisKIARF
KIARF
Kiaro Holdings Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
KIARF
  1. Home
  2. Stocks
  3. Kiaro Holdings Corp.
KI

Kiaro Holdings Corp.

🇺🇸KIARF•OTC
KI

Kiaro Holdings Corp.

🇺🇸KIARF•OTC
Market cap
$442

Your view on KIARF

Mkt Cap
$442
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Kiaro Holdings Corp.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
David Jenkins
Headquarters
110 East Cordova Street, Vancouver, BC, CA
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
David Jenkins
Headquarters
110 East Cordova Street, Vancouver, BC, CA
Description

Kiaro Holdings Corp. owns and operates cannabis retail stores in Canada. It operates through three segments: Retail Cannabis Stores, Wholesale Cannabis Business, and eCommerce. The company offers cannabis and cannabis related products.

The company also operates an eCommerce platform that offers consumption accessories in Canada, the United States, and Australia; and engages in the wholesale of cannabis products to other licensed retailers in Saskatchewan.

It sells its products through a network of seventeen stores in British Columbia, Saskatchewan, and Ontario, as well as online. Kiaro Holdings Corp. is headquartered in Vancouver, Canada.

FRC Research

Past Reports

Historical coverage archive.

1 report
Sep 3, 2021

A Growing Cannabis Retailer Led by Aurora’s Co-Founder – Initiating Coverage

PDF
Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Kiaro Holdings Corp.. Starting points for Kiaro Holdings Corp.: EPS -$0.42, beta 1.57 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Kiaro Holdings Corp.. Kiaro Holdings Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Kiaro Holdings Corp.. Trailing twelve-month EPS for Kiaro Holdings Corp. stands at -$0.42. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Kiaro Holdings Corp.. Kiaro Holdings Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold KIARF13 companies
Compare KIARF with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
RTGNRetinalGenix Technologies Inc.HealthcareMedical - Devices$59.5M
More Medical - Pharmaceuticals companies
TickerTypeCompanySectorExchangeMkt cap
BIEIPremier Biomedical, Inc.HealthcareOTC$599,989
BIO.AXBiome Australia LimitedHealthcareASX—
BIOVFSwedish Orphan Biovitrum AB (publ)HealthcareOTC$12.8B
BIOYFBioSyent Inc.HealthcareOTC$130.2M
BJTRFBeijing Tong Ren Tang Chinese Medicine Company LimitedHealthcareOTC$542.8M
BLMSBloomios, Inc.HealthcareOTC$6,447
BZYRBurzynski Research Institute, Inc.HealthcareOTC$3.4M
CBIACanopus BioPharma IncorporatedHealthcareOTC$455,071
CDXQChina De Xiao Quan Care Group Co., LtdHealthcareOTC$6,000
CELG-RIBristol-Myers Squibb Company CeHealthcareNYSE$143.2B
CHMEChina Medicine CorporationHealthcareOTC$829,922
CLABFCore One Labs Inc.HealthcareOTC$500
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Kiaro Holdings Corp., and how their positions are changing. At a $442 market value, institutional positions materially move Kiaro Holdings Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Kiaro Holdings Corp. executives and directors. Shares of Kiaro Holdings Corp. have traded between $0.0000 and $0.0051 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Kiaro Holdings Corp.. Kiaro Holdings Corp. is a $442 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Kiaro Holdings Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Kiaro Holdings Corp.. Coverage tracks Kiaro Holdings Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Kiaro Holdings Corp.

News

Latest Market News